THE sale of Massy Distribution (Jamaica) Limited (MDJL) to Acado Limited continues to remain on pause as the Fair Trading ...

By Anastasiia Kozlova and Purvi Agarwal (Reuters) -European shares inched higher on Wednesday, supported by mounting ...

Novo Nordisk faces setbacks with semaglutide in Alzheimer's trials and declining growth. Read here for analyst outlook and ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent.

Major stock indexes ended sharply higher Monday to begin a holiday-shortened trading week, with investors increasingly confident the Federal Reserve will cut interest rates at its December meeting.

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the ...

The U.S. Medicare health plan's negotiation for lower drug prices aims to save $8.5 billion by 2027. Prices for 15 expensive ...

Health-care companies rose sharply as regulatory fears faded. Shares of Danish drug maker Novo Nordisk rose, recouping some of their year-to-date losses after a weight-loss drug candidate helped ...

As pharmaceutical companies rapidly expand direct-to-consumer (DTC) models amid shifting US drug pricing reforms and the upcoming launch of TrumpRx, experts warn that these approaches introduce as ...

The US government said it negotiated a 71% discount on Novo Nordisk A/S’s blockbuster Ozempic and Wegovy drugs for patients ...

The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on ...

Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus wasn’t better than a placebo at delaying the progression of Alzheimer’s disease. It shared few details beyond saying the ...